News
Affymetrix reports 2Q loss on revenue dip
July 21, 2010 1:45 pm | by The Associated Press | CommentsAffymetrix Inc., which makes genetic testing technology, on Wednesday reported a second-quarter loss on as it booked fewer gains and product sales and services revenue both declined.The company posted a loss of $5.5 million, or 8 cents per share, compared with net income of $7.3 million, or 11...
RF Technologies® Announces Version 7 Software for Safe Place® Security Solutions
July 21, 2010 11:33 am | by Bio-Medicine.Org | CommentsBROOKFIELD, Wis. , July 21 /- RF Technologies®, a leading provider of radio frequency identification monitoring systems and healthcare security solutions, is announcing the release of Version 7 software for use with Safe Place® Infant and Pediatric Security Solutions. The...
SynDevRx stacks Series A round up to $1.2M
July 21, 2010 11:32 am | by Mass High Tech: The Journal of New England Technology | CommentsSynDevRx Inc., an anti-angiogenesis startup based in Cambridge, has added approximately $725,000 in funding to its previous tranche of what appears to be a Series A round, bringing the total raised to $1.24 million.
Zargis Awarded U.S. Army Contract
July 21, 2010 11:32 am | by Bio-Medicine.Org | CommentsSTAMFORD, Conn. , July 21 /- Zargis Medical Corp., a majority-owned subsidiary of Speedus Corp. (Nasdaq: SPDE ), today announced that it received a contract from the U.S. Army to develop an investigational device based on the success of the Signal-X6™ telemedicine systems recently...
SurgiVision slashes price of planned IPO
July 21, 2010 9:45 am | by The Associated Press | CommentsMedical device maker SurgiVision Inc. slashed the price of its expected initial public offering on Wednesday.The company, which makes devices designed to help physicians see inside a patient's body using MRI technology, plans to offer 2.5 million shares for $9 to $11 apiece for expected...
SemBiosys expands into Cambridge
July 21, 2010 9:34 am | by Mass High Tech: The Journal of New England Technology | CommentsSemBioSys Genetics Inc., a Calgary, Alberta, based developer of biosimilar drug candidates, proteins and oils, reports that it is opening a Cambridge office, and hiring a president of U.S. and international operations.
China Yongxin Pharmaceuticals Inc. Announces the Expansion of Its Chain of Retail Stores to 110 Stores
July 21, 2010 8:33 am | by Bio-Medicine.Org | CommentsCHANGCHUN, China and LOS ANGELES , July 21 /PRNewswire-Asia/ -- China Yongxin Pharmaceuticals Inc. (OTC Bulletin Board: CYXN) ("China Yongxin" or the "Company"), one of the leading health products distribution and retail sales companies in China , today announced the opening of seven new...
Trinity Orthopedics Receives Patent Allowance for Sagittally Stable Spinal Fixation System
July 21, 2010 8:33 am | by Bio-Medicine.Org | CommentsSAN DIEGO , July 21 /- Trinity Orthopedics LLC, a medical device company that develops and markets products for minimally invasive spine surgery, announced today that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for a monoplanar pedicle screw method,...
ID Experts Announces RADARâ„¢: A HITECH Risk Assessment Tool for Healthcare Security Breach Incidents Affecting Patient Privacy
July 21, 2010 8:33 am | by Bio-Medicine.Org | CommentsBEAVERTON, Ore. , July 21 /- Whenever there is a security breach of any size involving protected health information (PHI), the healthcare industry is now required under the HITECH Act to complete an incident-specific risk assessment. ID Experts®, the leader in comprehensive...
Latina Actress and Author Dayanara Torres Launches Online Asthma Education Resource for Hispanic Community in Partnership with Merck and AAFA
July 21, 2010 8:33 am | by Bio-Medicine.Org | CommentsMIAMI , July 21 /- Understanding and managing asthma is not always easy, especially without adequate patient resources. That's why Puerto Rican actress, author and mother of two children with asthma, Dayanara Torres , has partnered with the Asthma and Allergy Foundation of America (AAFA)...
EndoChoice® Triples Facility Space to Address Growing Customer Base
July 21, 2010 6:33 am | by Bio-Medicine.Org | CommentsALPHARETTA, Ga. , July 21 /- EndoChoice, Inc. today announced that it has moved its corporate headquarters to a new location in Alpharetta, Georgia . The new 30,000 square foot corporate headquarters is three times larger than its previous facility, and features a state-of-the-art...
Alere Inc. Schedules Conference Call for 10:00 a.m. ET July 28, 2010 to Discuss Second Quarter 2010 Results
July 21, 2010 6:32 am | by Bio-Medicine.Org | CommentsWALTHAM, Mass. , July 21 /- Alere Inc. (formerly known as Inverness Medical Innovations, Inc.) (NYSE: ALR ), a global leader in enabling individuals to take charge of their health at home through the merger of rapid diagnostics and health management, today announced that it will release...
Quest 2Q earnings rise, but outlook pummels shares
July 21, 2010 5:45 am | by The Associated Press | CommentsQuest Diagnostics reported that second-quarter net income climbed 3 percent, yet the medical laboratory operator cut its annual guidance Wednesday because of falling revenue and shares tumbled 8 percent before the market opened.Visits to doctors' offices fell with so many people out of work or...
BioMimetic raises $45 million in stock offering
July 21, 2010 5:45 am | by The Associated Press | CommentsBioMimetic Therapeutics Inc. said it generated about $45 million in proceeds after expenses from the sale of about 5.6 million shares in a public offering.The Franklin, Tenn., biotechnology company, which makes devices for musculoskeletal injuries, said Tuesday that underwriters exercised their...
Cara Therapeutics Secures $15 Million Series D Financing to Continue Clinical Development of CR845
July 21, 2010 5:34 am | by Bio-Medicine.Org | CommentsSHELTON, Conn. , July 21 /- Cara Therapeutics, Inc. announced today that it had closed on a Series D financing of $15 million . The round was led by new investor, Rho Ventures, with participation from previous investors Alta Biopharma, Ascent Biomedical Ventures, CT Innovations,...
